This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bensinger WI . Is there still a role for allogeneic stem-cell transplantation in multiple myeloma? Baillière's best practice & research. Clin Haematol 2007; 20: 783–795.
Miura Y, Azuma T, Kusumi E, Matsumura T, Kami M, Komatsu T . Graft-versus-myeloma effects in reduced-intensity cord blood transplantation. Int J Hematol 2007; 86: 463–465.
Barlogie B, Kyle RA, Anderson KC, Greipp PR, Lazarus HM, Hurd DD et al. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. J Clin Oncol 2006; 24: 929–936.
Bruno B, Rotta M, Patriarca F, Mattei D, Allione B, Carnevale-Schianca F et al. Non-myeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo. Blood 2008; e-pub ahead of print December 8.
Moreau P, Garban F, Attal M, Michallet M, Marit G, Hulin C et al. Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma. Blood 2008; 112: 3914–3915.
Bahlis NJ, Stewart DA, Savoie ML, Brown C, Daly A, Chaudhry A et al. Fludarabine-busulfan conditioning and in vivo T-cell depletion with reduced dose of ATG followed by allografting induces durable responses in patients with advanced multiple myeloma with no grade III–IV aGvHD. ASH Annual Meeting Abstracts 2006; 108: 3029.
Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Björkstrand B et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–1993 and 1994–1998 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001; 113: 209–216.
Palumbo A, Rajkumar SV . Treatment of newly diagnosed myeloma. Leukemia 2008; e-pub ahead of print November 13.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khaled, Y., Mellacheruvu, S., Reddy, P. et al. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect. Bone Marrow Transplant 44, 325–326 (2009). https://doi.org/10.1038/bmt.2009.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.14